Intellectual property law
fromMedCity News
1 day agoModerna to Pay Up to $2.25B to Settle Patent Suit Over Covid-19 Vaccine Technology - MedCity News
Moderna settles a patent dispute with Arbutus Biopharma and Genevant Sciences for $950 million upfront plus potentially over $1 billion more, acknowledging their lipid nanoparticle technology's role in Covid-19 vaccine development.